France eliminates clinical trial application fees
This article was originally published in SRA
Researchers in France no longer have to pay fees to register clinical trials with AFSSAPS, the national medicines regulator1. A provision in the country’s budget for this year took effect on 1 January, eliminating two fees that cost sponsors up to €6,000 per trial application. The changes are aimed at simplifying procedures.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.